{'Year': '2016', 'Month': 'Oct'}
Pharmacogenetics of efavirenz discontinuation for reported central nervous system symptoms appears to differ by race.
Efavirenz frequently causes central nervous system (CNS) symptoms. We evaluated genetic associations with efavirenz discontinuation for CNS symptoms within 12 months of treatment initiation.